Biofrontera (BFRI) Common Equity (2020 - 2026)
Biofrontera (BFRI) posted quarterly Common Equity of $10.5 million for Q4 2025, up 136.41% year-over-year from $4.4 million in Q4 2024, and up 506.04% quarter-over-quarter from -$2.6 million in Q3 2025.
Biofrontera (BFRI) Common Equity (2020 - 2026) Analysis & Trends
Biofrontera's Common Equity history runs 6 years deep, the most recent figure standing at $10.5 million for Q4 2025.
- In Q4 2025, Common Equity rose 136.41% year-over-year to $10.5 million; the TTM figure through Dec 2025 stood at $10.5 million (up 136.41% YoY), while the FY2025 annual figure was $10.5 million, up 136.41% from the prior year.
- Common Equity for Q4 2025 stood at $10.5 million, up from -$2.6 million in the prior quarter.
- The five-year high for Common Equity was $23.9 million in Q4 2022, with the low at -$17.4 million in Q3 2021.
- The 5-year median for Common Equity is $5.2 million (2023), against an average of $6.2 million.
- The sharpest annual moves came in 2022 and 2025: Common Equity jumped 1359.72% in 2022, then sank 146.67% in 2025.
- Biofrontera's Common Equity stood at $11.3 million in 2021, then surged by 110.6% to $23.9 million in 2022, then sank by 79.93% to $4.8 million in 2023, then dropped by 7.51% to $4.4 million in 2024, then soared by 136.41% to $10.5 million in 2025.
- Business Quant data shows BFRI's Common Equity at $10.5 million in Q4 2025, -$2.6 million in Q3 2025, and -$4.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96 Mn |
| Dec 31, 2025 | 10.48 Mn |
| Sep 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | -4.67 Mn |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Jun 30, 2024 | 10.91 Mn |
| Mar 31, 2024 | -5.42 Mn |
| Dec 31, 2023 | 4.79 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 7.17 Mn |
| Mar 31, 2023 | 16.75 Mn |
| Dec 31, 2022 | 23.88 Mn |
| Sep 30, 2022 | 22.60 Mn |
| Jun 30, 2022 | 17.23 Mn |
| Mar 31, 2022 | 17.42 Mn |
| Dec 31, 2021 | 11.34 Mn |
| Sep 30, 2021 | -17.38 Mn |
| Jun 30, 2021 | -1.37 Mn |